D, K., SP, C., P, K., MW, N., & N, S. (2024). Adherence to Guidelines and Federal Psychotropic Medication Labels for the Treatment of Medicaid-Insured Children With ADHD. Psychiatric services (Washington, D.C.), 75(11), 1151. https://doi.org/10.1176/appi.ps.20230369
Chicago Style (17th ed.) CitationD, Kim, Cuffe SP, Keskinocak P, Naylor MW, and Serban N. "Adherence to Guidelines and Federal Psychotropic Medication Labels for the Treatment of Medicaid-Insured Children With ADHD." Psychiatric Services (Washington, D.C.) 75, no. 11 (2024): 1151. https://doi.org/10.1176/appi.ps.20230369.
MLA (9th ed.) CitationD, Kim, et al. "Adherence to Guidelines and Federal Psychotropic Medication Labels for the Treatment of Medicaid-Insured Children With ADHD." Psychiatric Services (Washington, D.C.), vol. 75, no. 11, 2024, p. 1151, https://doi.org/10.1176/appi.ps.20230369.